Is There an Ethical Obligation to Disclose Controversial Risk? A Question From the ACCORD Trial

Author： DeMarco Joseph P.   Ford Paul J.   Patton Dana J.   Stewart Douglas O.  

Publisher： Routledge Ltd

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.14, Iss.4, 2014-04, pp. : 4-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs

By Silber Tomas J.  

American Journal of Bioethics, Vol. 14, Iss. 4, 2014-04 ,pp. : 52-52

Routledge Ltd

Access to resources Recommend Favorite

The Duty to Disclose Adverse Clinical Trial Results

By Liao S. Matthew   Sheehan Mark   Clarke Steve  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 24-32

Routledge Ltd

Access to resources Recommend Favorite

From Milestone to Moral Obligation

By  

Public Health Genomics, Vol. 10, Iss. 1, 2006-12 ,pp. : 1-1

Karger

Access to resources Recommend Favorite

The Duty to Disclose (Even More) Adverse Clinical Trial Results

By Hassoun Nicole  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 33-34

Routledge Ltd

Access to resources Recommend Favorite

Bariatric Surgery, Ethical Obligation, and the Life Cycle of Medical Innovation

By De Ville Kenneth  

American Journal of Bioethics, Vol. 10, Iss. 12, 2010-12 ,pp. : 22-24

Routledge Ltd

Access to resources Recommend Favorite